JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 27 No. 6 775-780
© 1986 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tyler, J.L.
Right arrow Articles by Feindel, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tyler, J.L.
Right arrow Articles by Feindel, W.

Pharmacokinetics of Superselective Intra-Arterial and Intravenous [11C]BCNU Evaluated by PET

J.L. Tyler , Y.L. Yamamoto, M. Diksic, J. Théron, J.G. Villemure, C. Worthington, A. C. Evans and W. Feindel

Brain Imaging Center, Montreal Neurological Institute and Hospital, and the Department of Neurology and Neurosurgery of McGill University

Correspondence: For reprints contact: Jane L. Tyler, MD, Brain Imaging Center, Montreal Neurology Institute and Hospital, 3801 University, Montreal, Quebec, Canada H3A 2B4.

ABSTRACT

The pharmacokinetics of i.v. and superselective intra-arterial carbon-11 1,3-bis-(2-chloroethyl)-1-nitrosourea ([11C]BCNU) were directly compared for the first time in ten patients with recurrent gliomas using positron emission tomography (PET). Intra-arterial administration of [11C]BCNU achieved concentrations of the drug in the tumor that averaged 50 times higher than with a comparable i.v. dose. These preliminary results suggest that the degree of early metabolic trapping of BCNU in tumor correlates with the clinical response to this chemotherapy.




This article has been cited by other articles:


Home page
The OncologistHome page
D. S. Boss, R. V. Olmos, M. Sinaasappel, J. H. Beijnen, and J. H. M. Schellens
Application of PET/CT in the Development of Novel Anticancer Drugs
Oncologist, January 1, 2008; 13(1): 25 - 38.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
Y. P. Gobin, T. F. Cloughesy, K. L. Chow, G. R. Duckwiler, J. W. Sayre, K. Milanese, and F. Viñuela
Intraarterial Chemotherapy for Brain Tumors by Using a Spatial Dose Fractionation Algorithm and Pulsatile Delivery
Radiology, March 1, 2001; 218(3): 724 - 732.
[Abstract] [Full Text]


Home page
Arch. Dis. Child.Home page
R O Robinson, C D Ferrie, M Capra, and M N Maisey
Positron emission tomography and the central nervous system
Arch. Dis. Child., September 1, 1999; 81(3): 263 - 270.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1986 by the Society of Nuclear Medicine.